Trials / Recruiting
RecruitingNCT05874479
Reducing AIR Pollution Exposure to Lower Blood PRESSURE Among New York City Public Housing Residents
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 440 (estimated)
- Sponsor
- NYU Langone Health · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
Fine particulate matter \<2.5 µm (PM2.5) air pollution is the fifth leading risk factor for global mortality, with the largest portion of deaths due to cardiovascular disease (CVD). While several mechanisms are responsible, PM2.5-induced elevations in blood pressure (BP) may be relevant. Indoor portable air cleaners (PACs) are a novel approach to reduce exposure to PM2.5 and potentially lower blood pressure. The current study is being conducted to provide evidence that PACs reduce PM2.5 exposure and lower systolic blood pressure (SBP) in key patient populations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Active PAC | The active PAC will contain HEPA filters inside the device. |
| DEVICE | Sham PAC | The sham PAC will contain no HEPA filters inside the device. |
Timeline
- Start date
- 2023-12-20
- Primary completion
- 2027-09-01
- Completion
- 2028-03-01
- First posted
- 2023-05-25
- Last updated
- 2025-10-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05874479. Inclusion in this directory is not an endorsement.